• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VIII 因子、血管性血友病因子和纤维蛋白原水平与黑人和白人静脉血栓栓塞风险的相关性。

High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.

出版信息

Ethn Dis. 2014 Spring;24(2):169-74.

PMID:24804362
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4618385/
Abstract

Venous thromboembolism (VTE) affects more than 300,000 people in the United States each year. However, it has been estimated that current diagnostic testing fails to identify prothrombotic risk in 50% of VTE patients. This article examines the relationship between levels of the pro-coagulant proteins factor VIII (FVIII), von Willebrand factor (VWF), and fibrinogen and risk of VTE in order to assess the impact of these novel risk factors. Data were collected from patients enrolled in the matched case-control Genetic Attributes and Thrombosis Epidemiology study. Crude and adjusted conditional logistic regression models were used to assess the impact of FVIII, VWF, and fibrinogen on risk of VTE. Before adjustment for independent predictors of VTE risk, high levels of FVIII, VWF, and fibrinogen were significantly associated with increased risk of VTE in both Blacks and Whites. After adjustment for ABO type, factor VII levels, hypertension, renal disease, recent surgery, diabetes, annual household income, alcohol use, and the other proteins of interest (FVIII, VWF, and/or fibrinogen), high FVIII and VWF levels were associated with increased risk of VTE in Blacks (OR: 1.97 [1.01-3.84] and 3.39 [1.58-7.27], respectively). High FVIII only was significantly associated with risk of VTE in Whites (OR: 2.35 [1.16-4.75]). Future research into the inclusion of these protein levels in risk models for VTE could help identify persons at highest risk.

摘要

静脉血栓栓塞症(VTE)影响了美国每年超过 30 万人。然而,据估计,目前的诊断检测未能识别出 50%的 VTE 患者存在血栓形成风险。本文研究了促凝蛋白因子 VIII(FVIII)、血管性血友病因子(VWF)和纤维蛋白原的水平与 VTE 风险之间的关系,以评估这些新的危险因素的影响。数据来自参加匹配病例对照遗传属性和血栓形成流行病学研究的患者。采用非条件逻辑回归模型来评估 FVIII、VWF 和纤维蛋白原对 VTE 风险的影响。在未调整 VTE 风险的独立预测因素之前,FVIII、VWF 和纤维蛋白原水平升高与黑人和白人的 VTE 风险增加显著相关。在调整 ABO 血型、因子 VII 水平、高血压、肾脏疾病、近期手术、糖尿病、家庭年收入、饮酒和其他感兴趣的蛋白质(FVIII、VWF 和/或纤维蛋白原)后,FVIII 和 VWF 水平升高与黑人 VTE 风险增加相关(比值比:1.97[1.01-3.84]和 3.39[1.58-7.27])。只有 FVIII 水平升高与白人 VTE 风险增加显著相关(比值比:2.35[1.16-4.75])。未来对这些蛋白水平纳入 VTE 风险模型的研究可能有助于确定风险最高的人群。

相似文献

1
High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.VIII 因子、血管性血友病因子和纤维蛋白原水平与黑人和白人静脉血栓栓塞风险的相关性。
Ethn Dis. 2014 Spring;24(2):169-74.
2
Histo-blood group ABO system transferase plasma levels and risk of future venous thromboembolism: the HUNT study.组织血型ABO系统转移酶血浆水平与未来静脉血栓栓塞风险:HUNT研究
Blood. 2025 May 29;145(22):2656-2665. doi: 10.1182/blood.2024025923.
3
Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans.以基因为中心的方法确定了欧洲裔美国人和非裔美国人中FVIII活性和VWF抗原水平的新的和已知的基因座。
Am J Hematol. 2015 Jun;90(6):534-40. doi: 10.1002/ajh.24005. Epub 2015 Apr 1.
4
High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor.高凝因子水平与静脉血栓风险:VIII 因子和血管性血友病因子相关性最强。
J Thromb Haemost. 2019 Jan;17(1):99-109. doi: 10.1111/jth.14343. Epub 2018 Dec 18.
5
Racial and regional differences in venous thromboembolism in the United States in 3 cohorts.美国 3 个队列中的静脉血栓栓塞的种族和地域差异。
Circulation. 2014 Apr 8;129(14):1502-9. doi: 10.1161/CIRCULATIONAHA.113.006472. Epub 2014 Feb 7.
6
Evaluation of risk factors for thromboembolic events in multiple myeloma patients using multiple machine learning models.使用多种机器学习模型评估多发性骨髓瘤患者血栓栓塞事件的危险因素。
Medicine (Baltimore). 2025 Feb 14;104(7):e41428. doi: 10.1097/MD.0000000000041428.
7
Family history of myocardial infarction is a risk factor for venous thromboembolism among whites but not among blacks.心肌梗死家族史是白人发生静脉血栓栓塞的危险因素,但不是黑人发生静脉血栓栓塞的危险因素。
Clin Appl Thromb Hemost. 2013 Jul-Aug;19(4):410-7. doi: 10.1177/1076029612448419. Epub 2012 Jun 12.
8
Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19.凝血生物标志物是 COVID-19 患者需氧量增加的独立预测因子。
J Thromb Haemost. 2020 Nov;18(11):2942-2953. doi: 10.1111/jth.15067. Epub 2020 Sep 18.
9
A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism.多阶段多设计策略提供了强有力的证据,表明 BAI3 基因座与早发性静脉血栓栓塞症有关。
J Thromb Haemost. 2010 Dec;8(12):2671-9. doi: 10.1111/j.1538-7836.2010.04092.x.
10
Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.2N 型血管性血友病小鼠中异常 von Willebrand 因子分泌、因子 VIII 稳定和血栓动力学。
J Thromb Haemost. 2017 Aug;15(8):1607-1619. doi: 10.1111/jth.13749. Epub 2017 Jul 17.

引用本文的文献

1
Uterine Fibroids and Their Association with Acute and Chronic Venous Thromboembolic Disease-An Expert Review of the Literature.子宫肌瘤及其与急慢性静脉血栓栓塞性疾病的关联——文献综述专家观点
J Clin Med. 2025 Jun 9;14(12):4065. doi: 10.3390/jcm14124065.
2
Evaluation of factors underlying differences in venous thromboembolism rates between Black and White patients.评估黑人和白人患者静脉血栓栓塞率差异的潜在因素。
J Vasc Surg Venous Lymphat Disord. 2025 Sep;13(5):102270. doi: 10.1016/j.jvsv.2025.102270. Epub 2025 May 26.
3
Determination of vWF, ADAMTS-13 and Thrombospondin-1 in Venous Thromboembolism and Relating Them to the Presence of Factor V Leiden Mutation.测定静脉血栓栓塞症中 vWF、ADAMTS-13 和血栓调节蛋白-1,并将其与因子 V Leiden 突变的存在相关联。
Clin Appl Thromb Hemost. 2024 Jan-Dec;30:10760296231223195. doi: 10.1177/10760296231223195.
4
Low-density lipoprotein promotes microvascular thrombosis by enhancing von Willebrand factor self-association.低密度脂蛋白通过增强血管性血友病因子的自缔合促进微血管血栓形成。
Blood. 2023 Sep 28;142(13):1156-1166. doi: 10.1182/blood.2023019749.
5
Laboratory-based inequity in thrombosis and hemostasis: review of the evidence.血栓形成与止血方面基于实验室的不平等现象:证据综述
Res Pract Thromb Haemost. 2023 Mar 15;7(2):100117. doi: 10.1016/j.rpth.2023.100117. eCollection 2023 Feb.
6
Contemporary Biomarkers in Pulmonary Embolism Diagnosis: Moving beyond D-Dimers.肺栓塞诊断中的当代生物标志物:超越D-二聚体
J Pers Med. 2022 Sep 29;12(10):1604. doi: 10.3390/jpm12101604.
7
Correlation between serum factor VIII:C levels and deep vein thrombosis following gynecological surgery.妇科手术后血清因子 VIII:C 水平与深静脉血栓形成的相关性。
Bioengineered. 2021 Dec;12(2):9668-9677. doi: 10.1080/21655979.2021.1981755.
8
Plasma levels of von Willebrand factor and future risk of incident venous thromboembolism.血浆血管性血友病因子水平与静脉血栓栓塞症的未来风险。
Blood Adv. 2021 Jan 12;5(1):224-232. doi: 10.1182/bloodadvances.2020003135.
9
Monitoring of Unfractionated Heparin in Severe COVID-19: An Observational Study of Patients on CRRT and ECMO.重症新型冠状病毒肺炎患者普通肝素的监测:对接受连续性肾脏替代治疗和体外膜肺氧合治疗患者的观察性研究
TH Open. 2020 Nov 19;4(4):e365-e375. doi: 10.1055/s-0040-1719083. eCollection 2020 Oct.
10
Molecular mechanisms for thrombosis risk in Black people: a role in excess mortality from COVID-19.黑人血栓形成风险的分子机制:在COVID-19导致的过高死亡率中的作用。
Br J Haematol. 2020 Jul;190(2):e78-e80. doi: 10.1111/bjh.16869. Epub 2020 Jun 8.

本文引用的文献

1
Elevated factor VIII levels and risk of venous thrombosis.VIII 因子水平升高与静脉血栓风险。
Br J Haematol. 2012 Jun;157(6):653-63. doi: 10.1111/j.1365-2141.2012.09134.x. Epub 2012 Apr 25.
2
Pulmonary embolism and deep vein thrombosis.肺栓塞与深静脉血栓形成。
Lancet. 2012 May 12;379(9828):1835-46. doi: 10.1016/S0140-6736(11)61904-1. Epub 2012 Apr 10.
3
Influence of single nucleotide polymorphisms in factor VIII and von Willebrand factor genes on plasma factor VIII activity: the ARIC Study.VIII 因子和血管性血友病因子基因中单核苷酸多态性对血浆 VIII 因子活性的影响:ARIC 研究。
Blood. 2012 Feb 23;119(8):1929-34. doi: 10.1182/blood-2011-10-383661. Epub 2012 Jan 4.
4
The acute phase reaction explains only a part of initially elevated factor VIII:C levels: a prospective cohort study in patients with venous thrombosis.急性相反应仅能解释部分患者初始升高的因子 VIII:C 水平:静脉血栓形成患者的前瞻性队列研究。
Thromb Res. 2012 Feb;129(2):183-6. doi: 10.1016/j.thromres.2011.09.024. Epub 2011 Oct 10.
5
Persistent high factor VIII activity leading to increased thrombin generation - a prospective cohort study.持续高的因子 VIII 活性导致凝血酶生成增加 - 一项前瞻性队列研究。
Thromb Res. 2012 Apr;129(4):447-52. doi: 10.1016/j.thromres.2011.07.020. Epub 2011 Aug 16.
6
Racial differences in venous thromboembolism.种族差异与静脉血栓栓塞症。
J Thromb Haemost. 2011 Oct;9(10):1877-82. doi: 10.1111/j.1538-7836.2011.04443.x.
7
Venous thromboembolism: a public health concern.静脉血栓栓塞症:公共健康关注点。
Am J Prev Med. 2010 Apr;38(4 Suppl):S495-501. doi: 10.1016/j.amepre.2009.12.017.
8
Venous thromboembolism in African-Americans: a literature-based commentary.非裔美国人的静脉血栓栓塞症:基于文献的评论。
Thromb Res. 2010 Jan;125(1):12-8. doi: 10.1016/j.thromres.2009.04.019. Epub 2009 Jul 1.
9
Assessing the coagulation factor levels, inherited thrombophilia, and ABO blood group on the risk for venous thrombosis among Brazilians.评估巴西人群中凝血因子水平、遗传性血栓形成倾向和ABO血型与静脉血栓形成风险的关系。
Clin Appl Thromb Hemost. 2009 Jul-Aug;15(4):408-14. doi: 10.1177/1076029607311777. Epub 2009 Apr 26.
10
Advances in understanding pathogenic mechanisms of thrombophilic disorders.血栓形成倾向疾病致病机制的理解进展
Blood. 2008 Jul 1;112(1):19-27. doi: 10.1182/blood-2008-01-077909.